ReviewFrontiers in plant science2025
Bibliometric analysis of global research trends and development prospects of
Review in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The In Vivo Existence Forms of Engeletin and Their Anti-Hyperuricemia Activity.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: All Chinese and English literatures pertaining to SGR was gathered from Web of Science Core Collection (WoSCC), China Knowledge Network (CNKI), Wanfang database, and VIP database, subsequently de-duplicated and organized, with CiteSpace software employed for visualization and analysis of the literature. Results: A total of 1723 articles were incorporated into the analysis, and the quantity of SGR-related publications in English persists in its upward trajectory. Sun Weifeng, Lisa Dong, and Zhang Qingfeng emerged as the principal contributors, while Beijing University of TCM and Zhejiang University of TCM established themselves as the foremost publishing organizations. Noteworthy, keywords indicative of contemporary research focal points encompassed "Chinese medicine treatment," "gout," "anti-inflammatory," and "network pharmacology." Discussion: The investigation into SGR concentrates on pharmaceuticals and their active components, therapeutic interventions, and pharmacological mechanisms. Recently, anti-inflammatory and cyberpharmacology have emerged as prominent trends, indicating that the integration of animal studies with molecular bioinformatics to investigate the pharmacological mechanism of SGR is the main research direction in the future, while cardiovascular protection and neuroprotective effects have become significant areas of recent inquiry. Consequently, SGR is anticipated to be a functional plant for the treatment of various diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.